(R,R)-Tramadol

(R,R)-Tramadol

SCHEMBL2678627

COc1cccc([C@@]2(O)CCCC[C@@H]2CN(C)C)c1.O=C(O)c1ccccc1C(=O)O

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1

The experimentally established mechanism targets of (R,R)-Tramadol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
OPRM1 known ✓ P35372 10/20 0.82
SLC6A2 P23975 11/20 0.82
SLC6A4 P31645 11/20 0.82
OPRD1 P41143 7/20 0.82
OPRK1 P41145 4/20 0.82
SLC22A1 O15245 3/20 0.82
MEN1 O00255 2/20 0.82
KMT2A Q03164 2/20 0.82
CHRM2 P08172 1/20 0.82
CHRM1 P11229 1/20 0.82
HTR3A P46098 1/20 0.54
HTR4 Q13639 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
(R,R)-Tramadol SCHEMBL2678948 0.94 SLC6A2 (0.76) SLC6A2SLC6A4OPRM1OPRD1OPRK1
Tramadol SCHEMBL4799725 0.94 SLC6A2 (0.76) SLC6A2SLC6A4OPRM1OPRD1OPRK1
(R,R)-Tramadol SCHEMBL2678357 0.92 SLC6A2 (0.82) SLC6A2SLC6A4OPRM1OPRD1OPRK1
Tramadol SCHEMBL4798126 0.92 SLC6A2 (0.82) SLC6A2SLC6A4OPRM1OPRD1OPRK1
(R,R)-Tramadol SCHEMBL2678195 0.92 SLC6A2 (0.89) SLC6A2SLC6A4OPRM1OPRD1OPRK1
(R,R)-Tramadol SCHEMBL18171987 0.91 SLC6A2 (0.71) SLC6A2SLC6A4OPRM1OPRD1OPRK1
(R,R)-Tramadol SCHEMBL1593740 0.91 SLC6A2 (1.00) SLC6A2SLC6A4OPRM1OPRD1OPRK1
(R,R)-Tramadol SCHEMBL730723 0.91 SLC6A2 (1.00) SLC6A2SLC6A4OPRM1OPRD1OPRK1
(R,R)-Tramadol SCHEMBL5318670 0.91 SLC6A2 (1.00) SLC6A2SLC6A4OPRM1OPRD1OPRK1
(R,R)-Tramadol SCHEMBL11984200 0.91 SLC6A2 (1.00) SLC6A2SLC6A4OPRM1OPRD1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173164-B2 Both active substances are contained in the same administration unit as two separately formulated subunits GRUENENTHAL GMBH (DE) 2012-05-08 US claimed
EP-1183015-B1 MULTILAYERED TABLET FOR ADMINISTRATION OF A FIXED COMBINATION OF TRAMADOL AND DICLOFENAC GRUENENTHAL GMBH (DE) 2004-10-20 EP claimed
US-20040115267-A1 Oral administration forms for administering a fixed tramadol and diclofenac combination GRUENENTHAL GMBH. 2004-06-17 US claimed
EP-1185253-B1 ORAL ADMINISTRATION FORM FOR ADMINISTERING A FIXED TRAMADOL AND DICLOFENAC COMBINATION GRUENENTHAL GMBH (DE) 2004-03-03 EP claimed
US-6558701-B2 Multilayer tablet for administering a fixed combination of tramadol and diclofenac GRUENENTHAL GMBH (DE) 2003-05-06 US claimed
US-20020156133-A1 Oral administration forms for administering a fixed tramadol and diclofenac combination GRUENENTHAL GMBH (DE) 2002-10-24 US claimed
US-20020132850-A1 Multilayer tablet for administering a fixed combination of tramadol and diclofenac GRUENENTHAL GMBH (DE) 2002-09-19 US claimed
US-8173164-B2 Both active substances are contained in the same administration unit as two separately formulated subunits GRUENENTHAL GMBH (DE) 2012-05-08 US disclosed
US-20040115267-A1 Oral administration forms for administering a fixed tramadol and diclofenac combination GRUENENTHAL GMBH. 2004-06-17 US disclosed
US-6558701-B2 Multilayer tablet for administering a fixed combination of tramadol and diclofenac GRUENENTHAL GMBH (DE) 2003-05-06 US disclosed
US-20020156133-A1 Oral administration forms for administering a fixed tramadol and diclofenac combination GRUENENTHAL GMBH (DE) 2002-10-24 US disclosed
US-20020132850-A1 Multilayer tablet for administering a fixed combination of tramadol and diclofenac GRUENENTHAL GMBH (DE) 2002-09-19 US disclosed